Compare BUR & THQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | BUR | THQ |
|---|---|---|
| Founded | 2009 | 2014 |
| Country | Guernsey | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Finance Companies |
| Sector | Finance | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 814.7M | 784.0M |
| IPO Year | 2017 | N/A |
| Metric | BUR | THQ |
|---|---|---|
| Price | $3.62 | $19.05 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $8.49 | N/A |
| AVG Volume (30 Days) | ★ 2.7M | 116.2K |
| Earning Date | 11-04-2026 | 01-01-0001 |
| Dividend Yield | 3.61% | ★ 7.53% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $413,360,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.86 | $16.28 |
| 52 Week High | $10.10 | $20.39 |
| Indicator | BUR | THQ |
|---|---|---|
| Relative Strength Index (RSI) | 49.91 | 56.39 |
| Support Level | $3.58 | $18.83 |
| Resistance Level | $4.50 | $19.41 |
| Average True Range (ATR) | 0.22 | 0.39 |
| MACD | 0.01 | 0.08 |
| Stochastic Oscillator | 34.04 | 64.00 |
Burford Capital Ltd provides capital against the underlying value of litigation and legal assets, known as legal finance, serving the legal industry with financial products and services. Its business is funding clients engaged in ongoing legal disputes to pay legal fees and monetize the expected future value of disputes, focusing on large, complex matters. The company has two reportable segments: Principal Finance, which earns maximum revenue and allocates capital to legal finance assets from its balance sheet and through interests in private funds managed by the company, and Asset Management and Other Services, which manages legal finance assets for third-party investors and provides other services to the legal industry.
abrdn Healthcare Opportunities Fund is a non-diversified closed-end fund in the United States. Its investment objective is to seek current income and long-term capital appreciation through investments in U.S. and non-U.S. companies. The fund invests in equity and debt securities of public and private healthcare companies believed by the Fund's Adviser to have potential for above-average growth, and may invest in private companies and other restricted securities, including private investments in public equity and venture capital investments, provided these securities comprise 10% or less of Managed Assets.